Comparative Study
Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters
- PMID: 285282
Item in Clipboard
Comparative Study
Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters
J Natl Cancer Inst.
1979 Apr.
Abstract
The tumorigenic effects of sc-implanted diethylstilbestrol (DES) on male Syrian golden hamsters and European hamsters were compared. The adenohypophyses, kidneys, and testes of both species showed neoplastic responses to DES treatment. European hamsters were more sensitive than were Syrian hamsters, inasmuch as the European hamsters had a higher tumor incidence. The testicular tumors were all Leydig cell adenomas and seemed to depend on the coincident occurrence of hypophyseal neoplasms (all composed of gonadotropic cells). Of the European hamsters tested, 29% also developed liver tumors (hepatocellular adenomas, carcinomas, and cholangiocarcinomas.
Similar articles
-
Morphometric analysis of renal cortex changes induced by diethylstilbestrol (DES) in Syrian hamsters.Res Commun Chem Pathol Pharmacol. 1992 Dec;78(3):341-58. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1475531
-
Carcinogenic effects of cycasin in Syrian golden hamsters and the transplantability of induced tumors.Cancer Res. 1971 Mar;31(3):283-7. Cancer Res. 1971. PMID: 4323111 No abstract available.
-
Effects of transplacental exposure to diethylstilbestrol on carcinogenic susceptibility during postnatal life in hamster progeny.Cancer Res. 1979 Nov;39(11):4636-44. Cancer Res. 1979. PMID: 115577
-
Hormone-related tumors in Syrian hamsters.Prog Exp Tumor Res. 1972;16:201-40. doi: 10.1159/000393373. Prog Exp Tumor Res. 1972. PMID: 4557234 Review. No abstract available.
-
Susceptibility and resistance to chemical carcinogens in inbred Syrian hamsters.Prog Exp Tumor Res. 1979;24:215-21. doi: 10.1159/000402098. Prog Exp Tumor Res. 1979. PMID: 395569 Review. No abstract available.
Cited by
-
Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas.Ann Surg. 1990 Aug;212(2):150-4. doi: 10.1097/00000658-199008000-00006. Ann Surg. 1990. PMID: 2165386 Free PMC article.
-
Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.Dig Dis Sci. 1992 May;37(5):659-62. doi: 10.1007/BF01296419. Dig Dis Sci. 1992. PMID: 1373360 Clinical Trial.
-
Renal cell carcinoma treatment during pregnancy: Histopathological findings suggestive of rapid tumor growth.IJU Case Rep. 2019 Jun 19;2(5):265-268. doi: 10.1002/iju5.12098. eCollection 2019 Sep. IJU Case Rep. 2019. PMID: 32743433 Free PMC article.
-
Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence.Cancers (Basel). 2021 Sep 13;13(18):4588. doi: 10.3390/cancers13184588. Cancers (Basel). 2021. PMID: 34572815 Free PMC article. Review.
-
Risk factors for renal cell carcinoma: results of a population-based case-control study.Cancer Causes Control. 1993 Mar;4(2):101-10. doi: 10.1007/BF00053150. Cancer Causes Control. 1993. PMID: 8481488